Intermediate hepatocellular carcinoma: current treatments and future perspectives
Author:
Funder
Bayer Italy
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/24/suppl_2/ii24/6674907/mdt054.pdf
Reference45 articles.
1. EASL-EORTC Clinical Practice Guidelines: management of hepatocellular carcinoma;European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer;J Hepatol,2012
2. Prognosis of hepatocellular carcinoma: the BCLC staging classification;Llovet;Semin Liver Dis,1999
3. Loco-regional treatment of hepatocellular carcinoma;Lencioni;Hepatology,2010
4. Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?;Lencioni;Oncologist,2010
5. The intermediate hepatocellular carcinoma stage: should treatment be expanded?;Piscaglia;Dig Liver Dis,2010
Cited by 69 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab versus Transarterial Chemoembolization Alone in Intermediate‐stage Hepatocellular Carcinoma: A Multicenter Retrospective Study;Journal of Hepatocellular Carcinoma;2024-06
2. Identification and Verification of a Glycolysis-Related lncRNA Prognostic Signature for Hepatocellular Carcinoma;Hormone and Metabolic Research;2024-05-21
3. Defining a radiomics feature selection method for predicting response to transarterial chemoembolization in hepatocellular carcinoma patients;Meta-Radiology;2024-03
4. Validation of a supplementary condition of eighth AJCC staging system for stage II hepatocellular carcinoma;European Journal of Surgical Oncology;2023-07
5. Efficacy of radiofrequency ablation following transarterial chemoembolisation combined with sorafenib for intermediate stage recurrent hepatocellular carcinoma: a retrospective, multicentre, cohort study;eClinicalMedicine;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3